IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 in Iovance between May 9, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - June 3, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) and reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/6455/254218_1fae950c045cdad2_001full.jpg ]
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Iovance's growth potential; notably, that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers.
On July 25, 2024, Iovance announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on 1) 'the iCTC completed annual scheduled maintenance in December' and 'capacity was reduced by more than half for about 1 month,' 2) "[l]ower Proleukin sales' than the company expected, and 3) 'the variable pace at which ATCs began treatment patients.'
Investors and analysts reacted immediately to Iovance's revelation. The price of Iovance's common stock declined dramatically. From a closing market price of $3.17 per share on May 8, 2025, Iovance's stock price fell to $1.75 per share on May 9, 2025, a decline of about 44.795% in the span of just a single day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Iovance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Iovance class action, go to www.faruqilaw.com/IOVA or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/254218
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Skift
11 minutes ago
- Skift
Making Sense of the JetBlue and United Partnership
We sort the speculation from the facts, contextualize the JetBlue-United deal, and ask what it really means for the carriers and the wider industry. For this episode of the Airline Weekly Lounge, hosts Gordon Smith and Jay Shabat delve into the recently announced partnership between JetBlue and United Airlines. They discuss the implications of this collaboration, the financial struggles faced by JetBlue, and the potential benefits for both airlines. The conversation also touches on regulatory considerations and industry reaction. Listen to This Podcast Apple Podcasts | Spotify | YouTube | RSS Takeaways
Yahoo
12 minutes ago
- Yahoo
Is Tesla Stock a Buy After Soaring in May?
Shares soared more than 23% in May as CEO Elon Musk recommitted to focusing on Tesla. A successful launch of Tesla's Robotaxi service could transform the company's growth trajectory. After a big run-up, the stock's valuation may already reflect much of the good news. These 10 stocks could mint the next wave of millionaires › Shares of electric-car maker Tesla (NASDAQ: TSLA) soared in May, climbing more than 23%. This was far greater than the S&P 500's 5.5% gain. The sharp move higher helped Tesla recover some of its losses from earlier in the year. Shares wrapped up the month down 14% year to date -- a big improvement from declines of more than 40% earlier this year. The growth stock's surge higher came as Tesla CEO Elon Musk announced that he is stepping down from President Trump's Department of Government Efficiency (DOGE) initiative. Investors are also probably encouraged by the company's progress toward launching a self-driving ride-sharing network in Austin this summer. The autonomous ride-hailing service, which Tesla calls Robotaxi, is expected to be a game-changer for the company and the stock if it is successful. One of the biggest reasons investors have been upbeat about Tesla stock recently is Musk's decision to begin winding down his involvement at DOGE at the beginning of last month. Musk said in Tesla's first-quarter earnings call that he would be "allocating far more of my time to Tesla," starting in May. Then, last week, the CEO went even further when he officially stepped down from the agency. Musk's ambitious leadership has been pivotal to Tesla's growth over the years, and his growing number of responsibilities outside of the company was seen as a negative for the company. It's not surprising, therefore, that the stock has regained some ground as Musk followed through with his plans to give Tesla more of his attention. Musk's attention comes at a time when Tesla is trying to reinvigorate sales growth. The company's automotive revenue fell 20% year-over-year in Q1. Investors are hoping that several major initiatives, including plans for new, lower-cost models and the launch of Robotaxi, will help revitalize Tesla's growth story. It would be difficult to overstate the importance of Tesla's Robotaxi service. Given Tesla stock's price-to-earnings ratio of more than 200 as of this writing, investors are clearly expecting strong revenue and earnings growth for years to come. A successful deployment of the company's planned autonomous ride-hailing network is key to this thesis. The reason investors are so bullish on Tesla's robotaxi service is that the company has emphasized that most of the vehicles it has delivered to customers already will be capable of being deployed into the fleet. This means that the company's service can potentially reach a significant scale quite quickly, as customers who opt into the service use their existing vehicles to share in the revenue generated from the service. Therefore, the main limiting factor once Tesla proves that the service is safe will be getting the Robotaxi network approved for operation in various jurisdictions. Musk said in a post on X in May that the company had already been testing self-driving Model Y vehicles without anyone in the driver's seat. So far, the tests have been incident-free, Musk said. This puts the service's rollout a "month ahead of schedule," he noted. Importantly, Tesla is hoping that the its planned launch of its Robotaxi service in Austin, along with its new models later this year, will fuel demand for its vehicles and return the company to strong growth. Indeed, Tesla chief financial officer Vaibhav Taneja said in the company's first-quarter earnings call in April that these two catalysts should solicit "a new era of demand" for the company. With Tesla seeming to approach a pivotal moment in which sales growth could spike, is the stock a buy today? While Wall Street is right to be more optimistic about the stock given recent news about Musk's increased involvement and the company's progress toward officially launching its autonomous ride-hailing service, the stock's recent move higher arguably already priced this news in. With this in mind, shares look more like a hold than a buy today. Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $366,219!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $38,589!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $656,825!* Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of June 2, 2025 Daniel Sparks and/or his clients have positions in Tesla. The Motley Fool has positions in and recommends Tesla. The Motley Fool has a disclosure policy. Is Tesla Stock a Buy After Soaring in May? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
16 minutes ago
- Bloomberg
Emerging-Market Assets Extend Gains as Korean Rally Continues
Emerging-market stocks rose for a third consecutive session, with South Korean assets extending their world-beating gains after a presidential election. MSCI's EM stock gauge is heading for 2.4% gains in the past three days. An index of developing-nation currencies also edged higher as the dollar has remained under pressure from investors expecting a more dovish Federal Reserve after softer US employment data.
